Navigation Links
CareToLive Reports: The FDA Fiddles While 30,000 Men Burn
Date:11/26/2007

DUBLIN, Ohio, Nov. 26 /PRNewswire/ -- /CTL/ -- CareToLive, a not for profit corporation, received a set back in a lower Federal Court last Wednesday in its fight against the FDA on behalf of terminal cancer patients. Undeterred, they announced that they will immediately file an appeal in the 6th Circuit Court in Ohio.

"Men are dying while a safe, effective treatment languishes outside of their grasp," said CareToLive spokesperson, Melody Davis. "Congress needs to wake up and hold hearings immediately! We are going to intensify our advocacy efforts on behalf of cancer patients. We feel the real reasons for the delay were financial and political conflicts. The FDA continues to ignore the cries of the 30,000 men dying of prostate cancer each year, and refuses to protect their health and well being as they are sworn to do."

"The evidence clearly shows our government violated these men's right to live," said Mike Kearney, a CareToLive board member. "They can say it, explain it, and infer it any way they want, but the truth is they allowed over 16,000 men to die since May 8th without treatment, while other men profited handsomely during their demise."

There has been only one approved treatment for late stage prostate cancer in over 42 years. The FDA decision was unprecedented in a late stage disease where the FDA special Advisory Panel of experts voted overwhelmingly that Provenge is safe and effective and no viable alternatives exist. Financially conflicted panel members, after failing to sabotage Provenge during the advisory meeting, "leaked" letters fraught with misinformation to improperly lobby FDA decision-makers and place public pressure on those decision-makers.

"The FDA makes up its rules as it goes along," Mr. Kearney continued, "and it does not follow its own rules, ignores congressional mandates and apparently answers to no one. The lower court indicated that the case is not reviewable as the FDA has not yet made a final decision on Provenge. It is a catch 22 situation because the FDA may never make a different decision than the one they already made which was not to approve. The Court basically said "we the people" have no recourse."

"Where are we headed if our government is left unchecked and allowed to violate the Constitutional rights of the very people they are sworn to protect?" asked CareToLive Attorney Kerry Donahue. "CareToLive organized rallies, took out a half page ad in the Washington Post, ran bus ads, wrote thousands of letters and lobbied Congress. We fought like hell but Congress remains asleep. We are going to stand up for these men's rights."

Scott Riccio, founding member, patient advocate and lobbyist for A Right To Live, who organized the recent rally at the FDA offices in conjunction with CareToLive, is continuing to focus on advocacy efforts aimed at Congress to hold public hearings on issues of FDA dysfunction, including the Provenge debacle. According to Mr. Riccio, the FDA fails to comply with its mission as established in the 1997 Food and Drug Administration Modernization Act (FDAMA). "This legislation clearly communicated to the FDA that Congress desired a change in Agency policies to not just protect the public from unsafe drugs but to also promote the public health by efficiently and promptly reviewing and delivering new therapies for patients fighting life threatening diseases like cancer," Mr. Riccio said. "There are very serious questions about the role conflicts of interest, internal politics, and outdated policies are playing at the FDA and getting answers to these questions would be greatly expedited by the holding of public hearings on the matter."

1 in 6 men will get prostate cancer in their lifetime. CareToLive is asking the public to help by contacting their elected officials to ask for a congressional hearing, visit the CareToLive website, digg their blogs, and join in the battle.

For information

http://www.CareToLive.com.

http://CareToLive.com/2007-11-15/the-time-is-now/

http://CareToLive.com/ways-to-help/

http://www.ARightToLive.com

http://www.Provenge.Blogspot.com

Contact Information:

E-mail:

Melody Davis, Public Relations - MDavis@caretolive.com

Mike Kearney - PublicRelations@caretolive.com

856-770-8540

Mailing Address:

CareToLive,

a not for profit corporation

P.O. Box 464

Thorofare, NJ 08086-0464


'/>"/>
SOURCE CareToLive
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. J.D. Power and Associates Reports: CIGNA HealthCare Recognized for Call Center Customer Satisfaction Excellence For a Second Consecutive Year
2. J.D. Power and Associates Reports: Hackensack University Medical Center Recognized as First Hospital to Achieve Distinction for Providing an Outstanding Inpatient Experience in All Four Service Areas
3. J.D. Power and Associates Reports: Rush-Copley Medical Center Recognized for Third Consecutive Year for Providing an Outstanding Inpatient Experience
4. Another Reason Not to Smoke While Pregnant: Birth Defects
5. Hospitals Improve Survival Rates While Treating Sicker Patients Thomson Healthcare Study Shows
6. Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize
7. Mecklenburg EMS Agency Launches Innovative Program to Pay Future EMTs While They Train
8. Former Congressman Hyde Awarded Presidential Medal of Freedom While Receiving Medical Rehabilitation at Marianjoy
9. Chronic kidney disease rises while most people with the condition remain unaware
10. 1 in 5 young Britons has sex with someone new while abroad
11. GNC Joins St. Jude Childrens Research Hospital(R) to Kick Off Fourth Annual Thanks And Giving(R) Campaign, Asking America to Help Save Childrens Lives While Shopping for the Holidays
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... IL (PRWEB) , ... October 13, 2017 , ... ... which established the certification process to promote standards of excellence for the field ... Symposium, scheduled for March 22 – 25, 2018 in Orlando, Florida at the ...
(Date:10/13/2017)... LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for care ... is the 90-day elimination period, when the family pays for care, is often waived, ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... be giving viewers the lowdown on sciatica in a new episode of "Success ... focuses on current events and innovation and investigates each subject in-depth with passion ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated ... in breathing. Oral appliances can offer significant relief to about 75 percent of ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... leader in post-acute health care, have expanded their existing home health joint venture ... , AccentCare has been operating a joint venture home health company with Asante, ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... The Rebound mobile app is poised to become ... tide of prescription drug addiction. The app empowers users to ... stepping down their dosage in a safe, controlled manner while ... the first 100,000 people to sign up will enjoy 3 ... ...
(Date:9/25/2017)... 25, 2017   Montrium , an industry ... today—from the IQPC Trial Master Files & Inspection ... that EastHORN Clinical Services has selected eTMF ... TMF management. EastHORN, a leading European contract research ... increase transparency to enable greater collaboration with sponsors, ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing ... of targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek ...
Breaking Medicine Technology: